Translocation Renal Cell Carcinoma t(6;11)(p21;q12) and Sickle Cell Anemia: First Report and Review of the Literature.
10.4111/kju.2014.55.2.145
- Author:
Damien CHASTE
1
;
Emmanuel VIAN
;
Gregory VERHOEST
;
Pascal BLANCHET
Author Information
1. Department of Urology, Rennes University Hospital, Rennes, France. damienchaste@gmail.com
- Publication Type:Case Report
- Keywords:
Hemoglobin SS;
Kidney cancer;
Renal cell carcinoma;
Sickle cell anemia;
Transcription factor EB
- MeSH:
Anemia, Sickle Cell*;
Carcinoma, Medullary;
Carcinoma, Renal Cell*;
Female;
Hemoglobin, Sickle;
Humans;
Kidney Neoplasms;
West Indies;
Young Adult
- From:Korean Journal of Urology
2014;55(2):145-147
- CountryRepublic of Korea
- Language:English
-
Abstract:
Translocation renal cell carcinoma (RCC) is a family of rare tumors recently identified in the pediatric and young adult population. We report the first case of a young woman from French West Indies with sickle cell anemia who developed a translocation RCC t(6;11)(p21;q12). Usually people with the sickle cell condition are known to develop renal medullary carcinoma (RMC). To our knowledge, this is the first case described in the literature of a translocation RCC associated with sickle cell disease. Here we discuss the relation between translocation RCC, RMC, and sickle cell disease.
